Perceived fatigability and metabolic and energetic responses to 6-minute walk test in older women.

OBJECTIVE: To determine the relationship between perceived fatigability and oxygen consumption, carbon dioxide production, respiratory exchange ratio and the energy cost of walking in older women. DESIGN: Observational, cross-sectional study. PARTICIPANTS: Forty-eight community-dwelling older women were recruited from senior centres in Natal, Rio Grande do Norte, Brazil. MAIN OUTCOME MEASURES: Participants were evaluated in two different sessions. In the first session, sociodemographic and clinical factors were assessed and accelerometers were delivered. In the second session, the 6-minute walking test (6MWT) was performed and expired gases were analysed. Self-reported levels of fatigue were evaluated on a numerical scale from 1 ('extremely energetic') to 7 ('extremely tired'). Severity scores for perceived and performance fatigability were calculated as the ratio of change in performance and fatigue, respectively, with walking distance. The O2 cost of walking was based on the oxygen consumption rate and the 6MWT walking speed. RESULTS: No correlation was found between the severity of perceived fatigability and metabolic measures. However, the severity of perceived fatigability was significantly correlated with greater O2 cost (r=0.579, P<0.01), physical activity (r=-0.654, P<0.01), walking distance (r=-0.712, P<0.01) and severity of performance fatigability (r=0.690, P<0.01). CONCLUSION: Perceived fatigability was not directly associated with metabolic measures; however, greater severity of perceived fatigability was associated with an increase in the O2 cost of walking. Important relationships were also found between greater severity of perceived fatigability and poor functional fitness, high level of energy expenditure and lower level of physical activity.

Low-level laser therapy to treat fibromyalgia.

Several clinical treatments have been proposed to manage symptoms of fibromyalgia. Low-level laser therapy (LLLT) may be a useful tool to treat this dysfunction. The aim of this study was to evaluate the effects of LLLT in patients with fibromyalgia. A placebo-controlled, randomized clinical trial was carried out with 20 patients divided randomly into either an LLLT group (n = 10) or a placebo group (n = 10). The LLLT group was treated with a GaAlAs laser (670 nm, 4 J/cm(2) on 18 tender points) three times a week over 4 weeks. Before and after treatment, patients were evaluated with the Fibromyalgia Impact Questionnaire (FIQ), McGill Pain Questionnaire, and visual analog scale (VAS). Data from the FIQ and McGill questionnaire for the treated and control groups were analyzed by paired t tests, and Wilcoxon tests were used to analyze data from the VAS. After LLLT or sham treatment, the number of tender points was significantly reduced in both groups (LLLT, p < 0.0001; placebo, p = 0.0001). However, all other fibromyalgia symptoms showed significant improvements after LLLT compared to placebo (FIQ, p = 0.0003; McGill, p = 0.0078; and VAS, p = 0.0020). LLLT provided relief from fibromyalgia symptoms in patients and should be further investigated as a therapeutic tool for management in fibromyalgia.